Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 30 days matching "Cystic Fibrosis"

ResearchPUBMEDToday

CACRC-Pan: A Concept Annotated Case Report Corpus and Processing Pipeline for Rare Pancreatic Diseases.

Researchers created a new computer tool that helps doctors identify rare pancreatic diseases by reading medical case reports. The tool learns to recognize symptoms described in patient stories and then suggests which disease a patient might have. Six rare pancreatic diseases are included: autoimmune pancreatitis (types 1 and 2), cystic fibrosis, hereditary chronic pancreatitis, pancreatic sufficiency, and Shwachman-Diamond syndrome.

WHY IT MATTERSThis tool could help doctors diagnose rare pancreatic diseases faster and more accurately by automatically identifying key symptoms in patient records, potentially reducing the years of diagnostic delay that patients with these conditions typically experience.
ℹ Good to knowAutoimmune pancreatitis type 1Autoimmune pancreatitis type 2Cystic fibrosis
ResearchBIORXIVMay 11

Preprint: PIKfyve influences inter-organelle contacts with lysosomes to modulate the endoplasmic reticulum

Scientists discovered that a protein called PIKfyve helps control how cells manage their internal structures, particularly the endoplasmic reticulum (a network inside cells that makes proteins) and lysosomes (the cell's cleanup compartments). When PIKfyve doesn't work properly, the endoplasmic reticulum becomes less flexible and organized. This research helps explain how cells maintain their internal organization and could eventually lead to treatments for diseases caused by PIKfyve problems.

WHY IT MATTERSThis research identifies PIKfyve's role in cellular organization, which is directly relevant to patients with PIKfyve-associated lysosomal storage disorders and neurological conditions caused by PIKfyve mutations, as understanding this mechanism could lead to targeted therapies.
👁 Watch this spaceMucolipidosis IVPIKfyve-associated lysosomal storage disorder

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases